BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 34333706)

  • 1. American Society of Breast Surgeons' Practice Patterns for Patients at Risk and Affected by Breast Cancer-Related Lymphedema.
    DeSnyder SM; Yi M; Boccardo F; Feldman S; Klimberg VS; Smith M; Thiruchelvam PTR; McLaughlin S
    Ann Surg Oncol; 2021 Oct; 28(10):5742-5751. PubMed ID: 34333706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-Year Breast Surgeon Experience in LYMPHA at Time of ALND for Treatment of Clinical T1-4N1-3M0 Breast Cancer.
    Herremans KM; Cribbin MP; Riner AN; Neal DW; Hollen TL; Clevenger P; Munoz D; Blewett S; Giap F; Okunieff PG; Mendenhall NP; Bradley JA; Mendenhall WM; Mailhot-Vega RB; Brooks E; Daily KC; Heldermon CD; Marshall JK; Hanna MW; Leyngold MM; Virk SS; Shaw CM; Spiguel LR
    Ann Surg Oncol; 2021 Oct; 28(10):5775-5787. PubMed ID: 34365563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the prevention and treatment of breast cancer-related lymphedema.
    Donahue PMC; MacKenzie A; Filipovic A; Koelmeyer L
    Breast Cancer Res Treat; 2023 Jul; 200(1):1-14. PubMed ID: 37103598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is bioimpedance spectroscopy a useful tool for objectively assessing lymphovenous bypass surgical outcomes in breast cancer-related lymphedema?
    Sutherland A; Wagner JL; Korentager S; Butterworth J; Amin AL; Balanoff CR; Hangge A; Larson KE
    Breast Cancer Res Treat; 2021 Feb; 186(1):1-6. PubMed ID: 33392840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining breast cancer-related lymphedema (BCRL) prevalence and risk factors: A pragmatic approach to lymphedema surveillance.
    Hing JX; Chua YN; Tan PT; Tan MSL; Mok CW; Seet MYL; Lin ZC; Seah CM; Lee WP; Tan SM
    Ann Acad Med Singap; 2024 Feb; 53(2):80-89. PubMed ID: 38920232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing Breast Cancer-Related Lymphedema (BCRL) Through Prospective Surveillance Monitoring Using Bioimpedance Spectroscopy (BIS) and Patient Directed Self-Interventions.
    Kilgore LJ; Korentager SS; Hangge AN; Amin AL; Balanoff CR; Larson KE; Mitchell MP; Chen JG; Burgen E; Khan QJ; O'Dea AP; Nye L; Sharma P; Wagner JL
    Ann Surg Oncol; 2018 Oct; 25(10):2948-2952. PubMed ID: 29987599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective, early longitudinal assessment of lymphedema-related quality of life among patients with locally advanced breast cancer: The foundation for building a patient-centered screening program.
    Gandhi A; Xu T; DeSnyder SM; Smith GL; Lin R; Barcenas CH; Stauder MC; Hoffman KE; Strom EA; Ferguson S; Smith BD; Woodward WA; Perkins GH; Mitchell MP; Garner D; Goodman CR; Aldrich M; Travis M; Lilly S; Bedrosian I; Shaitelman SF
    Breast; 2023 Apr; 68():205-215. PubMed ID: 36863241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective Surveillance with Compression for Subclinical Lymphedema: Symptoms, Skin, and Quality-of-Life Outcomes.
    Dietrich MS; Gaitatzis K; Koelmeyer L; Boyages J; Abramson VG; McLaughlin SA; Ngui N; Elder E; French J; Hsu J; Hughes TM; Stolldorf DP; Shah C; Ridner SH
    Lymphat Res Biol; 2023 Jun; 21(3):304-313. PubMed ID: 36126315
    [No Abstract]   [Full Text] [Related]  

  • 9. Bioimpedance spectroscopy for breast cancer-related lymphedema assessment: clinical practice guidelines.
    Shah C; Whitworth P; Valente S; Schwarz GS; Kruse M; Kohli M; Brownson K; Lawson L; Dupree B; Vicini FA
    Breast Cancer Res Treat; 2023 Feb; 198(1):1-9. PubMed ID: 36566297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of monitoring techniques on progression to chronic breast cancer-related lymphedema: a meta-analysis comparing bioimpedance spectroscopy versus circumferential measurements.
    Shah C; Zambelli-Weiner A; Delgado N; Sier A; Bauserman R; Nelms J
    Breast Cancer Res Treat; 2021 Feb; 185(3):709-740. PubMed ID: 33245458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of breast cancer-related arm lymphedema in physical functioning and physical activity participation among long-term African American breast cancer survivors.
    Nechuta S; Chen WY; Goerge A; Boopathy D; Sanderson M
    Support Care Cancer; 2024 Jun; 32(7):446. PubMed ID: 38900224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization of bioimpedance spectroscopy in the prevention of chronic breast cancer-related lymphedema.
    Kaufman DI; Shah C; Vicini FA; Rizzi M
    Breast Cancer Res Treat; 2017 Dec; 166(3):809-815. PubMed ID: 28831632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of bioelectrical impedance analysis for detection of lymphedema in breast Cancer survivors: a prospective cross sectional study.
    Lim SM; Han Y; Kim SI; Park HS
    BMC Cancer; 2019 Jul; 19(1):669. PubMed ID: 31286884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of Bioimpedance Spectroscopy with Risk Factors for the Development of Breast Cancer-Related Lymphedema.
    Vicini F; Shah C; Whitworth P; Walker M; Shi J
    Lymphat Res Biol; 2018 Dec; 16(6):533-537. PubMed ID: 30133336
    [No Abstract]   [Full Text] [Related]  

  • 15. Reducing rates of chronic breast cancer-related lymphedema with screening and early intervention: an update of recent data.
    Whitworth P; Vicini F; Valente SA; Brownson K; DuPree B; Kohli M; Lawson L; Shah C
    J Cancer Surviv; 2024 Apr; 18(2):344-351. PubMed ID: 35947288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node status and breast cancer-related lymphedema.
    Purushotham AD; Bennett Britton TM; Klevesath MB; Chou P; Agbaje OF; Duffy SW
    Ann Surg; 2007 Jul; 246(1):42-5. PubMed ID: 17592289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of perometry-based volumetric arm measurements and bioimpedance spectroscopy for early identification of lymphedema in a prospectively-screened cohort of breast cancer patients.
    Gillespie TC; Roberts SA; Brunelle CL; Bucci LK; Bernstein MC; Daniell KM; Naoum GN; Miller CL; Taghian AG
    Lymphology; 2021; 54(1):1-11. PubMed ID: 34506083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast Cancer-Related Lymphedema (BCRL) and Bioimpedance Spectroscopy: Long-Term Follow-Up, Surveillance Recommendations, and Multidisciplinary Risk Factors.
    Jeffers EJ; Wagner JL; Korentager SS; Larson KE; Balanoff CR; Baker J; Chollet-Hinton L; Kilgore LJ
    Ann Surg Oncol; 2023 Oct; 30(10):6258-6265. PubMed ID: 37535267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using the axillary reverse mapping technique to screen breast cancer patients with a high risk of lymphedema.
    Liu S; Wang N; Gao P; Liu P; Yang H; Xie F; Wang S; Liu M; Wang S
    World J Surg Oncol; 2020 Jun; 18(1):118. PubMed ID: 32482174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Lymphedema Surveillance Program for Breast Cancer Patients Reveals the Promise of Surgical Prevention.
    Hahamoff M; Gupta N; Munoz D; Lee BT; Clevenger P; Shaw C; Spiguel L; Singhal D
    J Surg Res; 2019 Dec; 244():604-611. PubMed ID: 29397949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.